Partner Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Partner Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-26,000	Closed	-$1.65M	–	112
2018 Q1	$1.65M	Buy	+26,000	New	+$1.67M	1.78%	20
2016 Q3	–	Sell	-32,600	Closed	-$2.4M	–	88
2016 Q2	$2.4M	Buy	32,600 +900	+3%	+$63.6K	3.92%	2
2016 Q1	$2.02M	Buy	31,700 +15,700	+98%	+$990K	3.3%	7
2015 Q4	$1.1M	Sell	16,000 -29,100	-65%	-$1.92M	1.81%	23
2015 Q3	$7K	Buy	+45,100	New	+$2.86M	0.01%	67
2014 Q1	–	Sell	-179,500	Closed	-$253K	–	77
2013 Q4	$253K	Buy	+179,500	New	+$9.14M	0.06%	54

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Partner Investment Management's BMY Position: Q2 2018 in Review

Partner Investment Management sold out of Bristol-Myers Squibb (BMY) in Q2 2018, closing a stake of 55,719 shares — an estimated $3.52M sold.

Partner Investment Management first reported a position in BMY in Q4 2013 and held it in 9 quarters. The position peaked at $39.2M in Q1 2014. 1,692 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

Partner Investment Management reported no remaining Bristol-Myers Squibb position as of Q2 2018 after selling out during the quarter.
Partner Investment Management sold 55,719 Bristol-Myers Squibb shares in Q2 2018, an estimated $3.52M.
Partner Investment Management first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 9 quarters.
Partner Investment Management's Bristol-Myers Squibb position peaked at $39.2M in Q1 2014.
1,692 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on Partner Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.